Mounjaro and Ozempic: Are They the Same for Weight Loss?

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro (tirzepatide) and Ozempic (semaglutide) are both prescription injectables prescribed for weight loss, yet they achieve results through fundamentally different biological pathways. While both belong to the incretin class of medications, tirzepatide activates two hormone receptors whereas semaglutide activates one, resulting in measurably different outcomes in clinical trials. PlexusDx offers both compounded versions, allowing patients to access personalized therapy tailored to their unique genetic profile.

How Tirzepatide and Semaglutide Work Differently in Your Body

Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it binds to and activates GLP-1 receptors throughout your body. This single-receptor mechanism slows stomach emptying, increases feelings of fullness, and helps regulate blood sugar. Tirzepatide, by contrast, is a dual-receptor agonist that activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously. This dual action creates a more comprehensive metabolic effect by engaging additional appetite-control pathways in the brain and gut.

The GIP receptor activation in tirzepatide appears to enhance the overall appetite-suppressing response beyond what GLP-1 activation alone can achieve. Research shows that dual-receptor activation may produce greater reductions in body weight compared to single-receptor therapy. However, individual response varies significantly based on genetic factors, lifestyle, and metabolic health—which is why personalized assessment matters before starting treatment.

Weight Loss Results: Clinical Trial Data Comparison

Clinical trials have demonstrated that tirzepatide produces greater average weight loss than semaglutide at similar treatment durations. In the SURMOUNT trials, patients using tirzepatide experienced up to 22% body weight reduction over 72 weeks at the highest dose, while semaglutide trials (STEP program) showed approximately 15% reduction at maximum dose over comparable periods. These differences suggest that the dual-receptor mechanism may offer an advantage for patients seeking maximum weight loss outcomes.

It is important to note that both medications work best when combined with lifestyle changes including nutrition adjustments and physical activity. Individual results depend on adherence to the treatment plan, starting weight, metabolic factors, and genetic predisposition to medication response. PlexusDx offers the Precision Peptide Genetic Test to identify your unique peptide-pathway profile, helping predict which therapy may align best with your genetic make-up.

Cost, Accessibility, and Compounding Pharmacy Differences

Brand-name Mounjaro and Ozempic are often expensive with insurance or without coverage, and many patients face significant out-of-pocket costs. PlexusDx provides compounded versions of both medications from licensed 503A compounding pharmacies at substantially lower price points: compounded semaglutide injection starts at $149 per month, while compounded tirzepatide injection starts at $249 per month. Neither requires insurance, a membership fee, or adherence to rigid dosing schedules—your dose may need to go up, but your price won't.

Compounded medications are legally produced in licensed 503A pharmacies under strict pharmaceutical standards and FDA oversight, ensuring quality and safety equivalent to brand products. PlexusDx serves all 50 states and accepts HSA and FSA funds, making therapy accessible to patients regardless of insurance status. The affordability and accessibility of compounded options has democratized access to these life-changing medications for millions of Americans.

Personalized Treatment: Why Your Genetic Profile Matters

Your response to tirzepatide or semaglutide is influenced by variations in your GLP-1 receptor genes, GIP receptor genes, and appetite-regulation genes like FTO and MC4R. The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide-related genes to identify your unique predispositions, including key variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313). This genetic insight helps your PlexusDx provider recommend whether tirzepatide, semaglutide, or a dual-compound therapy might optimize your weight loss outcomes.

Genetic testing is available as a $99 add-on after your first month of treatment, allowing your provider to refine your therapy based on objective molecular data. Rather than a one-size-fits-all approach, PlexusDx uses precision medicine to match you with the medication and dose strategy most likely to work for your body. This personalized strategy reduces trial-and-error, improves adherence, and maximizes the likelihood of achieving your weight loss goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro stronger than Ozempic for weight loss?

Clinical trials show tirzepatide (Mounjaro) produces greater average weight loss than semaglutide (Ozempic) across comparable time periods. However, individual results vary significantly based on genetics, lifestyle, and adherence. PlexusDx can help determine which medication may be better suited to your unique metabolic profile through genetic testing.

Can I switch from Ozempic to Mounjaro if I'm not seeing results?

Yes, switching between semaglutide and tirzepatide is an option if you are not achieving desired results after adequate trial and dose escalation. Your PlexusDx provider can evaluate your response and recommend whether a switch to tirzepatide, dose adjustment, or addition of a complementary compound might be appropriate. Genetic insight from the Precision Peptide test can guide this decision.

What does compounded tirzepatide cost at PlexusDx?

PlexusDx compounded tirzepatide injection starts at $249 per month across all commitment tiers. Your dose may need to go up, but your price won't—there are no flat per-compound pricing increases. The medication is produced by licensed 503A compounding pharmacies, requires no insurance, and is HSA/FSA eligible.

Are compounded semaglutide and tirzepatide as safe as brand-name versions?

Compounded medications from licensed 503A pharmacies are manufactured under FDA oversight and strict pharmaceutical quality standards equivalent to brand products. Both compounded semaglutide and tirzepatide maintain safety and efficacy profiles consistent with their brand counterparts when sourced through accredited facilities.

How does the Precision Peptide Genetic Test help me choose between these medications?

The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 additional metabolic pathways to predict your likelihood of response to semaglutide versus tirzepatide. This $99 add-on test, taken after your first month, provides objective data to help your provider optimize therapy selection and dosing strategy for your unique genetic makeup.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Mounjaro For Weight Loss 2
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.